
doi: 10.1038/480s46a
pmid: 22169802
Stem-cell transplants are an important tool for treating myeloma. But with improved drug alternatives, doctors disagree about the best time to give the treatment.
Male, Consensus, Time Factors, Middle Aged, Survival Analysis, Transplantation, Autologous, Drug Resistance, Neoplasm, Recurrence, Humans, Patient Participation, Multiple Myeloma, Stem Cell Transplantation
Male, Consensus, Time Factors, Middle Aged, Survival Analysis, Transplantation, Autologous, Drug Resistance, Neoplasm, Recurrence, Humans, Patient Participation, Multiple Myeloma, Stem Cell Transplantation
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
